251
Participants
Start Date
October 31, 2010
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Succinate Metoprolol (Betaloc ZOK®)
treatment with 47.5mg for two weeks, if tolerated and without Systolic blood pressure\<100mmHg and heart rate \<45 bpm according to 12-lead Electrocardiogram at Week 3, the dosage will be titrated to 95mg and last for another 6 weeks
Succinate Metoprolol (Betaloc ZOK®)
Treatment with 95mg for two weeks, and if tolerated and without bradycardia symptoms presented, Systolic blood pressure\<100mmHg and heart rate \<45 bpm according to 12-lead Electrocardiogram at Week 3，the dosage will be force titrated to 190mg and last for another 6 weeks
Research Site, Beijing
Research Site, Guangzhou
Research Site, Tangshan
Research Site, Zhengzhou
Research Site, Nanjing
Research Site, Jingzhou
Research Site, Shenyang
Research Site, Shanghai
Research Site, Taiyuan
Research Site, Tianjing
Lead Sponsor
AstraZeneca
INDUSTRY